Systematic Evaluation of Velocity-selective Arterial Spin Labeling Settings for Placental Perfusion Measurement
Overview
Authors
Affiliations
Purpose: Placental function is key for successful human pregnancies. Perfusion may be a sensitive marker for the in vivo assessment of placental function. Arterial spin labeling (ASL) MRI enables noninvasive measurement of tissue perfusion and it was recently suggested that ASL with velocity-selective (VS) labeling could be advantageous in the placenta. We systematically evaluated essential VS-ASL sequence parameters to determine optimal settings for efficient placental perfusion measurements.
Methods: Eleven pregnant women were scanned at 3T using VS-ASL with 2D multislice echo planar imaging (EPI)-readout. One reference VS-ASL scan was acquired in all subjects; within subgroups the following parameters were systematically varied: cutoff velocity, velocity encoding direction, and inflow time. Visual evaluation and region of interest analyses were performed to compare perfusion signal differences between acquisitions.
Results: In all subjects, a perfusion pattern with clear hyperintense focal regions was observed. Perfusion signal decreased with inflow time and cutoff velocity. Subject-specific dependence on velocity encoding direction was observed. High temporal signal-to-noise ratios with high contrast on the perfusion images between the hyperintense regions and placental tissue were seen at ~1.6 cm/s cutoff velocity and ~1000 ms inflow time. Evaluation of measurements at multiple inflow times revealed differences in blood flow dynamics between placental regions.
Conclusion: Placental perfusion measurements are feasible at 3T using VS-ASL with 2D multislice EPI-readout. A clear dependence of perfusion signal on VS labeling parameters and inflow time was demonstrated. Whereas multiple parameter combinations may advance the interpretation of placental circulation dynamics, this study provides a basis to select an effective set of parameters for the observation of placenta perfusion natural history and its potential pathological changes.
Sadiku E, Sun L, Macgowan C, Seed M, Morrison J Front Cardiovasc Med. 2024; 11:1426593.
PMID: 39108671 PMC: 11300254. DOI: 10.3389/fcvm.2024.1426593.
Seiter D, Chen R, Ludwig K, Zhu A, Shah D, Wieben O Placenta. 2024; 150:72-79.
PMID: 38615536 PMC: 11065564. DOI: 10.1016/j.placenta.2024.03.012.
Yin Y, Clark A, Collins S IEEE Trans Med Imaging. 2024; 43(7):2707-2717.
PMID: 38478454 PMC: 11571065. DOI: 10.1109/TMI.2024.3376668.
The human placenta project: Funded studies, imaging technologies, and future directions.
Herrera C, Kim M, Do Q, Owen D, Fei B, Twickler D Placenta. 2023; 142:27-35.
PMID: 37634371 PMC: 11257151. DOI: 10.1016/j.placenta.2023.08.067.
Herrera C, Wang Y, Udayakumar D, Xi Y, Do Q, Lewis M Eur Radiol. 2023; 33(12):9223-9232.
PMID: 37466705 PMC: 10796849. DOI: 10.1007/s00330-023-09945-x.